30.09.2014 • News

Moody Reviews German Merck’s Credit Rating

The US credit ratings agency Moody's has said it is reviewing the credit rating of German chemicals and pharmaceuticals producer Merck KGaA in connection with the company's plans to acquire laboratory products specialist Sigma-Aldrich.

Merck currently has a rating of A3.

Moody's said that while the acquisition makes sense strategically, the purchase price of over €13 billion would more than triple the Darmstadt-based company's debt burden to more than €17 billion.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read